The expression levels of 35 immune checkpoints, including PD-1, PD-L1, PD-L2, CTLA4, CD276, CD28, and CD27, which have been recently investigated in GBM, were significantly different between the two groups [47]. The gene discussed is PDCD1LG2; the disease is glioblastoma.